Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas. Gynecol Oncol. 1994 Apr; 53(1):84-92.
View in:
PubMed
subject areas
Adenocarcinoma
Adenocarcinoma
Adenocarcinoma, Clear Cell
Adenocarcinoma, Clear Cell
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Biomarkers, Tumor
Biomarkers, Tumor
Carcinoma, Endometrioid
Carcinoma, Endometrioid
Cystadenocarcinoma, Papillary
Cystadenocarcinoma, Papillary
Endometrial Neoplasms
Endometrial Neoplasms
ErbB Receptors
ErbB Receptors
Female
Female
Formaldehyde
Formaldehyde
Humans
Humans
Immunohistochemistry
Immunohistochemistry
Middle Aged
Middle Aged
Multivariate Analysis
Multivariate Analysis
Nuclear Proteins
Nuclear Proteins
Oncogene Proteins, Viral
Oncogene Proteins, Viral
Paraffin Embedding
Paraffin Embedding
Predictive Value of Tests
Predictive Value of Tests
Prognosis
Prognosis
Proliferating Cell Nuclear Antigen
Proliferating Cell Nuclear Antigen
Proportional Hazards Models
Proportional Hazards Models
Receptor, ErbB-2
Receptor, ErbB-2
Retrospective Studies
Retrospective Studies
Survival Analysis
Survival Analysis
Tissue Fixation
Tissue Fixation
Tumor Suppressor Protein p53
Tumor Suppressor Protein p53
authors with profiles
Robert S Mannel